Order results by:
| Issue | Title | |
| Vol 10, No 4 (2018) | Research Institute of Internal and Preventive Medicine, Branch, Federal Research Center, Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences | Abstract similar documents |
| A. V. Titarenko, S. V. Shishkin, L. V. Shcherbakova, E. G. Verevkin, M. Holmes, M. Bobak, S. K. Malyutina | ||
| "... groups, which was steeper in women than in men (p<0.001). Persons aged 70 years and older showed negative ..." | ||
| Vol 14, No 2 (2022) | Cognitive functions and professional status in the open population of Russia/Siberia among adults aged 25–44 years | Abstract PDF (Eng) similar documents |
| A. V. Sukhanov, M. I. Voevoda, E. A. Gromova, D. V. Denisova, V. V. Gafarov | ||
| "... ; Bourdon Test (BT); exclusion of “the fifth extra” test; verbal fluency test (naming animals in 1 min ..." | ||
| Vol 15, No 2 (2023) | Cognitive disorders in amyotrophic lateral sclerosis | Abstract similar documents |
| M. A. Kutlubaev, D. K. Areprintceva, E. V. Pervushina, L. V. Brylev | ||
| "... by speech fluency disorders, various aphasic disorders, disorders of regulatory functions, social cognitive ..." | ||
| Vol 16, No 3 (2024) | Cognitive impairment in neuromyelitis optica spectrum disorders | Abstract similar documents |
| E. A. Vekhina, D. S. Kasatkin, S. E. Korchevnyi, K. I. Bereznyak | ||
| "... memory and fluency. A significant influence on the severity of CI in NMOSD have the patient's age ..." | ||
| Vol 13, No 4 (2021) | Influence of genetic and comorbid emotional-affective factors on pre-mild cognitive decline in middle-aged patients | Abstract similar documents |
| N. N. Koberskaya, T. M. Ostroumova, V. A. Perepelov, D. S. Smirnov | ||
| "... time (verbal fluency test, trail making test, part A, digit symbol substitution test, and Munsterberg ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents | Abstract similar documents |
| M. D. Bogdanova, T. T. Batysheva, Yu. V. Mikadze, R. Ts. Bembeeva, E. Yu. Volkova | ||
| "... , psychometric techniques were used to assess attention, controlling functions, memory, verbal fluency ..." | ||
| Vol 9, No 3 (2017) | Use of computer stimulating programs in patients with post-stroke cognitive impairment | Abstract similar documents |
| S. V. Prokopenko, T. V. Dyadyuk, E. Yu. Mozheyko, A. F. Bezdenezhnykh, T. D. Koryagina, T. S. Anay-Ool | ||
| "... statistically better in indicators, such as speech fluency (by 33.0%), dynamic praxis (by 23.3%), a simple ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments | Abstract similar documents |
| I.S. Preobrazhenskaya | ||
| "... , a significant increase in speech fluency (p<0.00000) and attention level (p< 0.00000), and a decrease ..." | ||
| Vol 17, No 2 (2025) | Validation of the Russian-language version of the Self-Awareness Deficit Interview (SADI) | Abstract similar documents |
| N. A. Varako, Yu. V. Gridasova, M. S. Kovyazina, D. G. Yusupova, A. A. Zimin, A. B. Zaytsev, S. A. Vasileva, V. D. Daminov, Yu. P. Zinchenko, Yu. A. Sandalova, M. A. Piradov, N. A. Suponeva | ||
| "... criteria: verified neurological diagnosis, no pronounced speech disorders, Russian language fluency ..." | ||
| Vol 15, No 1 (2023) | Efficacy of a combination of non-drug therapies in patients with non-dementia vascular cognitive impairment | Abstract similar documents |
| M. S. Novikova, V. V. Zakharov, N. V. Vakhnina | ||
| "... .0. Categorical and literal fluency increased from 14.9±4.1 to 16.5±4.6 and from 10.0±1.7 to 11.6±1 ..." | ||
| Vol 15, No 4 (2023) | Comorbid disorders and therapy of persistent postural perceptual dizziness | Abstract similar documents |
| E. N. Zastenskaya, L. M. Antonenko | ||
| "... .80 to 29.6±12.80 points (p<0.001), in the group with PPPD and peripheral vestibular disorders – from 49 ..." | ||
| Vol 15, No 4 (2023) | Psychosocial factors and sleep disorders in the population aged 25–64 years in Russia/Siberia (International WHO MONICA-Psychosocial Programme) | Abstract similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. V. Gafarova | ||
| "... of: anxiety (HLA) in 61.8% of men (χ2=56.169; df=4; p<0.001) and 68.1% of women (χ2=36.535; df=4; p<0.001 ..." | ||
| Vol 15, No 2 (2023) | Quality of life of patients with rheumatoid arthritis and comorbid fibromyalgia | Abstract similar documents |
| N. A. Melikova, E. S. Filatova, E. G. Filatova, A. M. Lila | ||
| "... at rest was 7 and 4 cm (p<0.001), the average score on the CSI questionnaire was 50 and 38.5 (p<0.001 ..." | ||
| Vol 17, No 1 (2025) | The use of antipsychotics in the real-world clinical practice in Russia (based on the results of the EPIDEMICUS program) | Abstract similar documents |
| V. E. Medvedev | ||
| "... . For other mental disorders, doctors more frequently added quetiapine to the therapy (23.2%; p<0.001 ..." | ||
| Vol 13, No 3 (2021) | Validation of a Russian version of the Berg Balance Scale | Abstract similar documents |
| N. A. Suponeva, D. G. Yusupova, A. A. Zimin, A. B. Zaitsev, K. A. Yatsko, D. A. Melchenko, A. A. Rimkevichus, E. S. Zhirova, A. S. Taratukhina, A. S. Rizvanova, G. A. Gatina, M. E. Kalinkina, M. A. Piradov, K. Berg | ||
| "... points), reliability (Pearson's correlation coefficient r=0.98, р<0.0001; Cronbach's alpha α=0.94 р<0.001 ..." | ||
| Vol 14, No 4 (2022) | Smoking and sleep disorders (population-based study under the WHO “MONICA-psychosocial” program) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelgorn, A. V. Gafarova | ||
| "... – 12.2%) and 78.6% of women (satisfactory sleep – 58.9%, poor sleep – 19.7%; χ2 =38.553; df=2; p<0.001 ..." | ||
| Vol 15, No 6 (2023) | NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational study | Abstract similar documents |
| A. B. Danilov, A. A. Pilipovich, M. V. Pyastolova | ||
| "... on the VAS before treatment versus 10 [0; 20] after treatment; p<0.0001) and normalisation of sleep in most ..." | ||
| Vol 13, No 5 (2021) | Awareness of cardiovascular diseases risk factors, attitude towards their health and sleep disorders among the 25–64 years old population in Russia/Siberia (WHO International «MONICA-psychosocial» program) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelhorn, A. V. Gafarova | ||
| "... that they were «not entirely healthy» (men – 65.5%, χ2 =57.825, df=8, p<0.001 and women – 69.6%, χ2 =96.883, df=4 ..." | ||
| Vol 12, No 6 (2020) | Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke | Abstract PDF (Eng) similar documents |
| S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, К. V. Sobyanin | ||
| "... .7 [30.5; 39.9] ml/m2 vs 28.5 [25.6; 34.6] ml/m2 vs 27.1 [24.5; 31.2] ml/m2 ; p< 0.001) and NT-proBNP ..." | ||
| Vol 15, No 6 (2023) | Chronic dizziness: modern treatment methods taking into account comorbidity | Abstract similar documents |
| E. N. Zastenskaia, L. M. Antonenko | ||
| "... decreased from 45.59±15.47 to 29.9±12.56 points (p<0.001), the severity of anxiety according to BAI from 27 ..." | ||
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... completely (in 42% of participants) or became subclinical (in 48%; р<0.001). CI severity also reduced ..." | ||
| Vol 8, No 1 (2016) | Changes in spastic muscles of patients with infantile cerebral palsy according to ultrasound findings | Abstract similar documents |
| S. V. Vlasenko, G. M. Kushnir, T. F. Golubeva, E. A. Osmanov, E. V. Strashko | ||
| "... ), and age at contracture formation (R=0.60; p=0.001). Analysis of USG and electromyographic findings ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... scores of the MoCA (p=0.004), the 12- word recall test (p=0.0003), and the tests of literal (p=0.001 ..." | ||
| Vol 11, No 1 (2019) | Role of the intact hemisphere in determining the rehabilitation potential in the acute period of ischemic stroke: a diffusion and perfusion model | Abstract similar documents |
| N. A. Kaileva, A. A. Kulesh, N. Kh. Gorst, A. Yu. Bykova, V. E. Drobakha, K. V. Sobyanin, I. N. Shardakov, V. V. Shestakov | ||
| "... NIHSS value (r = 0.55; p < 0.001), the size of a focus (r = 0.42; p < 0.001), FA in the contralateral ..." | ||
| Vol 11, No 1 (2019) | Social support and stroke risk: an epidemiological study of a population aged 25–64 years in Russia/Siberia (the WHO MONICA-psychosocial program) | Abstract PDF (Eng) similar documents |
| A. V. Gafarova, E. A. Gromova, D. О. Panov, I. V. Gagulin, E. A. Krymov, V. V. Gafarov | ||
| "... .8% of women (χ2=22.603; df=2; p=0.0001) and a low SNI in 43.5% of men and in 33.9% of women (χ2=21.546; df=2 ..." | ||
| Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
| E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
| "... .05-0.001). There were statistically significant differences in the measures of short-term (5.9±0 ..." | ||
| Vol 7, No 1 (2015) | Vascular cognitive impairments in chronic kidney disease | Abstract similar documents |
| I. V. Rogova, V. V. Fomin, I. V. Damulin, E. G. Minakova, O. Yu. Selivanova, Yu. A. Petleva | ||
| "... –IV than in those with Stages I–II, as shown by the scores of the mini-mental state examination (p<0.001 ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... was decreased in patients in group 2 (p<0.001), asymmetry of the indicator was noted, in several patients ..." | ||
| Vol 16, No 3 (2024) | Fremanezumab in real-life clinical practice: specialized headache center experience | Abstract similar documents |
| Yu. E. Azimova, K. V. Skorobogatikh, V. V. Osipova, D. Z. Korobkova, N. V. Vashchenko, E. Z. Mamkhegov, A. S. Galanina, E. A. Guziy | ||
| "... .2 (before treatment) to 8.5±7.9 after 12 weeks (p<0.0001), in the EM group from 10.9±4.1 to 3.6±3.7 (p<0.0001 ..." | ||
| Vol 17, No 3 (2025) | Efficacy and safety of intravenous thrombolytic therapy in patients with ischemic stroke and mild neurological deficit | Abstract similar documents |
| M. R. Suleymanova, T. V. Danilova, D. R. Khasanova | ||
| "... ,84)=1882; p<0.001) and a better functional outcome according to the modified Rankin Scale (U(82,84)=1854; p ..." | ||
| Vol 13, No 3 (2021) | Sleep disorder trends in 1988–2018 among the 25–64 years old population in Russia/Siberia (WHO MONICA Psychosocial study) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelgorn, A. V. Gafarova | ||
| "... (χ2 =122.061; υ=16; p<0.001 – men; χ2 =230.626; υ=16; p<0.001 – women). In 1988–2018 there was a 2 ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... from 19.8 to 23.3 points (p≥0.001) was observed in the omberacetam group. In other groups, an increase ..." | ||
| Vol 14, No 3 (2022) | The impact of non-motor disorders on the quality of life of patients with cervical muscular dystonia | Abstract similar documents |
| M. R. Nodel, N. I. Salouhina, V. A. Tolmacheva | ||
| "... <0.001 ), moderate strength correlation – with indicators of anxiety (r=0.65; p<0 ..." | ||
| Vol 14, No 3 (2022) | Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia | Abstract similar documents |
| T. I. Nasonova, E. V. Parfenova | ||
| "... ; p<0.001), sleepiness according to ESS (8.2±4.6 and 6.2±4.6 points; p=0.014), somatization according ..." | ||
| Vol 15, No 3 (2023) | Clinical effectiveness and safety of prolonged release form of alimemazine in patients with generalized anxiety disorder | Abstract similar documents |
| Ju. E. Azimova, Yu. P. Sivolap, K. A. Ishchenko | ||
| "... .27 (p<0.0001). The proportion of patients with a decrease in the total score on the HARS scale by 50 ..." | ||
| Vol 16, No 4 (2024) | Kinesiotherapy in painful diabetic polyneuropathy | Abstract similar documents |
| E. V. Mandra, V. A. Parfenov, L. T. Akhmedzhanova, E. S. Shulakova, V. V. Fadeev, M. V. Amosova | ||
| "... .80 ± 1.06 points respectively after 6 months (p < 0.001), reduction in neuropathic pain according to NTSS ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Demographic and comorbid factors associated with the development of medication overuse headache | Abstract similar documents |
| Ia. A. Kniazeva, D. V. Gilev, V. V. Osipova, E. R. Lebedeva | ||
| "... occurred more frequently in the MOH group (53 and 16%, respectively; p<0.001; OR 5.9; 95% CI 3.6–9.8). One ..." | ||
| Vol 17, No 3 (2025) | Autonomic cardiovascular dysregulation and other non-motor manifestations of Parkinson’s disease | Abstract similar documents |
| A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov | ||
| "... I (p<0.0001), cognitive and affective disturbances, sleep disorders, worse NMSQ scores (p=0 ..." | ||
| Vol 16, No 6 (2024) | Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR) | Abstract similar documents |
| V. E. Medvedev, A. N. Bogolepova, D. P. Morozov, B. B. Kvasnikov | ||
| "... .6 points – by 2.6±3.3, 6.7±5.3 and 10.9±4.9 points, respectively, compared to baseline (p<0.0001 for all ..." | ||
| Vol 13, No 3 (2021) | Off-label antipsychotics prescription to adolescents with acute psychotic episodes does not cause adverse drug reactions | Abstract PDF (Eng) similar documents |
| D. V. Ivashchenko, N. I. Buromskaya, A. D. Malakhova, N. A. Tsarkova, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... potentially dangerous drug interactions (35.2% vs. 16.15%; p=0.0001) and prescriptions with duplicates drug ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... , USA). Results and discussion. We found a significant (p<0.001) decrease in the thickness ..." | ||
| Vol 14, No 3 (2022) | Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation | Abstract similar documents |
| O. D. Ostroumova, T. M. Ostroumova | ||
| "... compared to warfarin (p<0.0001), including a 51% greater hemorrhagic stroke (HS) risk reduction (p<0.0001 ..." | ||
| Vol 14, No 4 (2022) | Anxiety-depressive spectrum disorders in cervical dystonia | Abstract similar documents |
| V. A. Tolmacheva, P. G. Yuzbashyan, D. S. Petelin, B. A. Volel, N. I. Salouhina, M. R. Nodel, D. V. Romanov | ||
| "... with the control group (p<0.001). Anxiety symptoms show a significant dependence on the clinical severity of CD ..." | ||
| Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
| Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
| "... for the following domains: physical functioning (p<0.01), role-physical functioning (p<0.001), pain intensity (p<0 ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... and anxiety (p < 0.001). Vortioxetine demonstrated an optimal balance between tolerability and clinical ..." | ||
| Online-first | Association of carriers of single nucleotide polymorphisms rs1143634 and rs16944 in gene Il-1B and rs6265 in gene BDNF with temporal lobe epilepsy | Abstract similar documents |
| Y. S. Panina, D. V. Dmitrenko, N. A. Shnayder, E. V. Egorova, A. A. Usoltseva | ||
| "... % CI: 1.31-3.08; p = 0.001) and the homozygous genotype CC (OR = 2.48; 95% CI: 1.47-4.17; p = 0.001 ..." | ||
| Vol 9, No 4 (2017) | Membrane characteristics and vascular cognitive impairment | Abstract PDF (Eng) similar documents |
| Yu. V. Zhitkova, D. R. Khasanova, V. N. Oslopov | ||
| "... predominance of not only the total number of dementias (86.7% of the patients in IV quartile; p<0.001 ..." | ||
| Vol 10, No 1 (2018) | Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, V. A. Parfenov, O. D. Ostroumova, E. M. Perepelova, V. A. Perepelov, E. V. Borisova | ||
| "... regions was significantly (p < 0.001) lower than that in the controls: right CBF, 39.1±5.6 and 45.8±3.2 ml ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Analysis of the clinical experience with perampanel in the Moscow Region: Efficacy, tolerability, individual choice priorities | Abstract similar documents |
| I. G. Rudakova, Yu. A. Belova | ||
| "... %, respectively; p = 0.0001), but those with temporal lobe epilepsy and isolated regional EEG patterns were 2–3 ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... . The latency of the P100 wave increased dramatically and differed significantly (p<0.001) from those ..." | ||
| Vol 2, No 4 (2010) | Novelty in the treatment of episodic tension-type headache | Abstract similar documents |
| G. R. Tabeeva, Yu. E. Azimova | ||
| "... .085). The efficacy predictors were less pain intensity (p < 0.001) and a shorter time after onset (p < 0.001 ..." | ||
| Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
| N. V. Zarubina, N. N. Spirin | ||
| "... and exacerbations (p<0.001). MS patients with depression significantly more often (p<0.01) complained of increased ..." | ||
| Vol 15, No 6 (2023) | In-hospital mortality in patients with ischemic stroke and a large cerebral artery occlusion, who underwent mechanical thrombectomy | Abstract similar documents |
| D. M. Murtazalieva, A. R. Zakaryaeva, M. A. Zolotov | ||
| "... with MTE was only 7.2%, while the proportion of patients on basic therapy was 36.9% (p<0.001). Mortality ..." | ||
| Vol 16, No 1 (2024) | Evaluation of the therapeutic efficacy of the drug Cytochrome C in the treatment of asthenia in outpatients (CITRIN study) | Abstract similar documents |
| V. Yu. Lobzin, A. Yu. Emelin, K. A. Kolmakova | ||
| "... (p<0.001), improvement in night sleep and reduction in daytime sleepiness on the Epworth scale by 65 ..." | ||
| Vol 16, No 1 (2024) | Safety and efficacy of fremanezumab in real clinical practice in patients with chronic migraine | Abstract similar documents |
| G. N. Belskaya, A. V. Krasnikov, E. A. Kiryanova, M. E. Prokopovich, E. V. Sakharova, G. V. Makarov | ||
| "... to 5.7 points (p<0.001), the HIT-6 index decreased from 66 to 55 points (p<0.001). AEs occurred in 26 ..." | ||
| Vol 16, No 4 (2024) | Treatment of post-traumatic cognitive disorders and asthenia: results of an observational study | Abstract similar documents |
| P. R. Kamchatnov, O. Yu. Tsarapkina, N. G. Malyukova, A. V. Miretskaya, E. F. Danshina, L. A. Skipetrova, R. A. Cheremin | ||
| "... by 16.2 seconds, part A of the TMT – by 6.6 seconds and part B – by 19.8 seconds (p < 0.0001 ..." | ||
| Vol 16, No 6 (2024) | Efficacy of cognitive behavioral therapy in chronic migraine and medication overuse headache: a prospective randomized trial | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... and in 45% in group 2 (p < 0.001). After 18 months of therapy, the clinical effect was observed in 79 ..." | ||
| Vol 8, No 2 (2016) | Effectiveness of prolonged-release melatonin in Improving Quality of Sleep in Patients Aged 55 or Over | Abstract similar documents |
| G. V. Kovrov, M. V. Agaltsov, Z. N. Sukmarova | ||
| "... significant (p<0.0001) according to pared t-test (95% CI: 4.8; 7.3) improvement of the sleep quality: the mean ..." | ||
| Vol 9, No 4 (2017) | The course of cervical dystonia with head tremor during botulinum toxin type A treatment | Abstract similar documents |
| A. N. Korenko, A. A. Skoromets, A. A. Timofeeva, A. V. Tishkov | ||
| "... ; 41] to 30 [27; 33] scores by injection cycle 4 (p < 0.001) and to 26 [23; 27] scores by cycle 8 (p<0 ..." | ||
| Vol 16, No 3 (2024) | Clinical and neurophysiological features of the augmentation phenomenon in restless legs syndrome | Abstract similar documents |
| N. A. Gorbachev, A. V. Obukhova, L. A. Fedeneva, M. G. Poluektov | ||
| "... unpleasant sensations over the entire surface of the legs (p=0.01), painful discomfort in the legs (p=0.001 ..." | ||
| Vol 13, No 4 (2021) | Methionine synthase reductase A66G polymorphism and ischemic stroke in younger patients | Abstract similar documents |
| O. V. Tsyganenko, L. I. Volkova, A. M. Alasheev | ||
| "... .029). In addition, protein C level was significantly lower in patients with MTRR A66G mutation (р=0.001 ..." | ||
| Vol 13, No 3 (2021) | From accurate diagnosis to targeted therapy: depression in general medical practice | Abstract similar documents |
| N. N. Petrova | ||
| "... combination (p < 0.001). Hypertensive patients had the highest depression prevalence (87%) and severity ..." | ||
| Vol 12, No 4 (2020) | Experience with citicoline in patients with post-stroke cognitive impairment | Abstract similar documents |
| A. N. Bogolepova, S. G. Burd, A. V. Lebedeva, E. A. Kovalenko | ||
| "... administration showed a statistically significant reduction in the severity of cognitive impairment (p<0.001 ..." | ||
| No 1S (2016): | Analysis of adult patients with epilepsy in the age continuum | Abstract similar documents |
| V. A. Karlov, O. S. Inozemtseva | ||
| "... of anxiety, severity of seizures, and scores of the QOLIE-89 questionnaire (p<0.001). Since the patients ..." | ||
| Vol 10, No 2 (2018) | Interventional medicine techniques in the treatment of nonspecific low back pain caused by sacroiliac joint dysfunction | Abstract similar documents |
| A. V. Kavelina, A. I. Isaikin, M. A. Ivanova | ||
| "... months after a treatment cycle, there were reductions in the intensity of pain (by an average of 47%; p<0.0001 ..." | ||
| Vol 16, No 2 (2024) | The central vein sign in the diagnosis of multiple sclerosis | Abstract similar documents |
| Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, O. N. Voskresenskaya | ||
| "... in the comparison group (p<0.001). The 40% lesion rule had a sensitivity of 97.5% and a specificity of 94 ..." | ||
| Vol 16 (2024): (Suppl. 2) | Combined analysis of free kappa chains and central vein sign increases the specificity of multiple sclerosis diagnosis | Abstract similar documents |
| Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
| "... patients compared to the control group (p<0.001). The sensitivity of the integrated laboratory ..." | ||
| Vol 14, No 5 (2022) | Results of ELBRUS clinical non-interventional study | Abstract similar documents |
| D. O. Rozhkov, K. V. Shevtsova, V. V. Grinyuk, V. A. Parfenov | ||
| "... according to HADS (p<0.001). The duration of treatment was 14.14±3.6 days on average. No adverse events were ..." | ||
| Vol 13, No 5 (2021) | Insomnia in chronic non-specific low back pain | Abstract similar documents |
| I. A. Lamkova, V. A. Parfenov | ||
| "... intensity according to NRS significantly decreased in a week and after 3 months, compared to baseline (р<0.0001 ..." | ||
| 1 - 70 of 110 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
